ELISA Kits

The HPV6 E7/pRb Binding Assay Kit uses a rapid, simple, and sensitive method to characterize the binding affinity between HPV type 6 E7 oncoprotein and its receptor Retinoblastoma in the presence of potential inhibitors within 4 hours. 4-8 week development phase.

The HPV6 E7/pRb Binding Assay Kit uses a rapid, simple, and sensitive method to characterize the binding affinity between HPV type 6 E7 oncoprotein and its receptor Retinoblastoma in the presence of potential inhibitors within 4 hours. 4-8 week development phase.

The HPV6 L1/ITGA6-ITGB4 Binding Assay Kit uses a rapid, simple, and sensitive method to characterize the binding affinity between HPV type 6 major capsid protein and its receptor ITGA6-ITGB4 dimer in the presence of potential inhibitors within 4 hours. 4-8 week development phase.

The HPV6 L1/ITGA6-ITGB4 Binding Assay Kit uses a rapid, simple, and sensitive method to characterize the binding affinity between HPV type 6 major capsid protein and its receptor ITGA6-ITGB4 dimer in the presence of potential inhibitors within 4 hours. 4-8 week development phase.

The HPV6 L1/ITGA6-ITGB4 Binding Assay Kit uses a rapid, simple, and sensitive method to characterize the binding affinity between HPV type 6 major capsid protein and its receptor ITGA6-ITGB4 dimer in the presence of potential inhibitors within 4 hours. 4-8 week development phase.

The HPV6 L1/Laminin-332 Binding Assay Kit uses a rapid, simple, and sensitive method to characterize the binding affinity between HPV type 6 major capsid protein and its receptor Laminin 332 in the presence of potential inhibitors within 4 hours. 4-8 week development phase.

The HPV6 L1/Laminin-332 Binding Assay Kit uses a rapid, simple, and sensitive method to characterize the binding affinity between HPV type 6 major capsid protein and its receptor Laminin 332 in the presence of potential inhibitors within 4 hours. 4-8 week development phase.

The HPV6 L1/Laminin-332 Binding Assay Kit uses a rapid, simple, and sensitive method to characterize the binding affinity between HPV type 6 major capsid protein and its receptor Laminin 332 in the presence of potential inhibitors within 4 hours. 4-8 week development phase.

The RayBiotech HPV11 E6 protein Human IgG ELISA Kit is an in-vitro indirect ELISA for the semi-quantitative measurement of human IgG antibody against HPV type 11 E6 protein in human serum or plasma. This ELISA kit is for research use only, not for therapeutic or diagnostic applications.